Neutrophil-activating peptide-2 and melanoma growth-stimulatory activity are functional as monomers for neutrophil activation. 1997

K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
Protein Engineering Network of Centres of Excellence (PENCE) and the Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2S2, Canada. kkr@rigel.biochem.ualberta.ca

Neutrophil-activating peptide-2 (NAP-2) and melanoma growth-stimulatory activity (MGSA) are members of the chemokine family of inflammatory proteins. The structures of NAP-2, determined by x-ray crystallography, and MGSA, elucidated by NMR spectroscopy, revealed a tetramer and dimer, respectively. In order to address the relevance of multimeric species to their activities on neutrophils, analogs of NAP-2 and MGSA were synthesized in which the backbone amide proton of Leu-22 in NAP-2, and Val-26 in MGSA, was substituted with the bulky methyl group (NH --> NCH3). These analogs were shown to be monomeric by sedimentation equilibrium ultracentrifugation studies and were similar to the corresponding native protein in assays for neutrophil elastase release and Ca2+ mobilization from IL-8R1 and IL-8R2 transformed cells. Sedimentation equilibrium studies of the native NAP-2 and MGSA were also carried out to address the association behavior. For NAP-2, there was no evidence for the tetramer, but an equilibrium between monomers and dimers and the dissociation constant was calculated to be 50-100 microM. Similarly, MGSA showed a monomer-dimer equilibrium with a Kd of approximately 5 microM. The data from the monomeric analogs and also the calculation of dissociation constants indicate that NAP-2 and MGSA have a tendency to associate above the concentrations required for maximal activity or for receptor activation, but at functional concentrations they are predominantly monomers.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D006133 Growth Substances Signal molecules that are involved in the control of cell growth and differentiation. Mitogens, Endogenous,Endogenous Mitogens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D001620 beta-Thromboglobulin A platelet-specific protein which is released when platelets aggregate. Elevated plasma levels have been reported after deep venous thrombosis, pre-eclampsia, myocardial infarction with mural thrombosis, and myeloproliferative disorders. Measurement of beta-thromboglobulin in biological fluids by radioimmunoassay is used for the diagnosis and assessment of progress of thromboembolic disorders. beta-2 Thromboglobulin,Thromboglobulin, beta-2,beta 2 Thromboglobulin,beta Thromboglobulin
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D054360 Chemokine CXCL1 A CXC chemokine with specificity for CXCR2 RECEPTORS. It has growth factor activities and is implicated as a oncogenic factor in several tumor types. CXCL1 Chemokine,Chemokine (C-X-C Motif) Ligand 1,GROalpha Protein,Gro-alpha Protein,Growth-Related Oncogene alpha Protein,MGSA-alpha Chemokine,Melanoma Growth Stimulatory Activity, alpha Protein,Neutrophil-Activating Protein 3,CXCL1, Chemokine,Chemokine, CXCL1,Chemokine, MGSA-alpha,Gro alpha Protein,Growth Related Oncogene alpha Protein,MGSA alpha Chemokine,Neutrophil Activating Protein 3
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies

Related Publications

K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
June 1991, The Journal of biological chemistry,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
March 1993, Molecular immunology,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
May 1990, The Journal of experimental medicine,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
October 1996, The Journal of biological chemistry,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
December 1986, Journal of cellular physiology,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
February 1995, The Journal of biological chemistry,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
January 1992, Cytokines,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
February 1988, Archives of biochemistry and biophysics,
K Rajarathnam, and C M Kay, and B Dewald, and M Wolf, and M Baggiolini, and I Clark-Lewis, and B D Sykes
May 2002, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Copied contents to your clipboard!